CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

Kapil Dixit is a graduate of the Indian Institute of Mass Communications. He has covered crime at regional as well as state ...

Trump is correct. Too many drug prices are too high. How pharmacy benefit managers help inflate the prices of drugs in ...

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often ...

Medicaid doesn’t need price controls from other countries; it already imposes them here. Under the program’s existing “Best ...

Pharmaceutical companies have little incentive to sell drugs to countries that can’t afford them. But bargaining together can ...

Cancer patients say they’ve grown sicker since Argentina’s radical libertarian President Javier Milei took his chainsaw to ...

New data from GoodRx Research reveals just how inadequate and restrictive prescription insurance has become. Medicaid, often ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of policies being considered by Health and Human Services Secretary Robert F.

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The Chief Medical Director of Phalycon Clinic in Bauchi, Dr Hassan Garba, has attributed the rising costs of consumables and ...

NEW ORLEANS (WVUE) - Where and how Louisiana residents get their prescriptions filled became a key focus during the state’s latest legislative session. Two bills—House Bill 264 and House Bill ...